nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—ALB—acquired immunodeficiency syndrome	0.515	1	CbGaD
Auranofin—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0958	0.511	CbGbCtD
Auranofin—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0919	0.489	CbGbCtD
Auranofin—PRDX5—skin of body—acquired immunodeficiency syndrome	0.0052	0.0783	CbGeAlD
Auranofin—PRDX5—lymphoid tissue—acquired immunodeficiency syndrome	0.00421	0.0634	CbGeAlD
Auranofin—PRDX5—digestive system—acquired immunodeficiency syndrome	0.00416	0.0627	CbGeAlD
Auranofin—PRDX5—blood—acquired immunodeficiency syndrome	0.00396	0.0597	CbGeAlD
Auranofin—PRDX5—bone marrow—acquired immunodeficiency syndrome	0.00383	0.0578	CbGeAlD
Auranofin—PRDX5—spinal cord—acquired immunodeficiency syndrome	0.00382	0.0575	CbGeAlD
Auranofin—PRDX5—vagina—acquired immunodeficiency syndrome	0.00367	0.0553	CbGeAlD
Auranofin—PRDX5—lung—acquired immunodeficiency syndrome	0.00347	0.0523	CbGeAlD
Auranofin—PRDX5—nervous system—acquired immunodeficiency syndrome	0.00322	0.0485	CbGeAlD
Auranofin—PRDX5—central nervous system—acquired immunodeficiency syndrome	0.0031	0.0467	CbGeAlD
Auranofin—IKBKB—skin of body—acquired immunodeficiency syndrome	0.00308	0.0464	CbGeAlD
Auranofin—IKBKB—lymphoid tissue—acquired immunodeficiency syndrome	0.00249	0.0376	CbGeAlD
Auranofin—IKBKB—digestive system—acquired immunodeficiency syndrome	0.00246	0.0371	CbGeAlD
Auranofin—PRDX5—brain—acquired immunodeficiency syndrome	0.00246	0.037	CbGeAlD
Auranofin—PRDX5—lymph node—acquired immunodeficiency syndrome	0.00238	0.0358	CbGeAlD
Auranofin—IKBKB—blood—acquired immunodeficiency syndrome	0.00235	0.0354	CbGeAlD
Auranofin—IKBKB—vagina—acquired immunodeficiency syndrome	0.00218	0.0328	CbGeAlD
Auranofin—IKBKB—lung—acquired immunodeficiency syndrome	0.00206	0.031	CbGeAlD
Auranofin—IKBKB—nervous system—acquired immunodeficiency syndrome	0.00191	0.0287	CbGeAlD
Auranofin—IKBKB—central nervous system—acquired immunodeficiency syndrome	0.00183	0.0276	CbGeAlD
Auranofin—IKBKB—brain—acquired immunodeficiency syndrome	0.00146	0.0219	CbGeAlD
Auranofin—IKBKB—lymph node—acquired immunodeficiency syndrome	0.00141	0.0212	CbGeAlD
Auranofin—PRDX5—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.0011	0.0654	CbGpPWpGaD
Auranofin—PRDX5—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.001	0.0596	CbGpPWpGaD
Auranofin—ALB—brain—acquired immunodeficiency syndrome	0.00085	0.0128	CbGeAlD
Auranofin—ALB—lymph node—acquired immunodeficiency syndrome	0.000821	0.0124	CbGeAlD
Auranofin—ALB—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.000738	0.044	CbGpPWpGaD
Auranofin—PRDX5—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000648	0.0386	CbGpPWpGaD
Auranofin—IKBKB—EBV LMP1 signaling—CCL5—acquired immunodeficiency syndrome	0.000637	0.038	CbGpPWpGaD
Auranofin—Neuropathy peripheral—Efavirenz—acquired immunodeficiency syndrome	0.000635	0.00296	CcSEcCtD
Auranofin—Anaemia—Nevirapine—acquired immunodeficiency syndrome	0.000634	0.00296	CcSEcCtD
Auranofin—Jaundice—Efavirenz—acquired immunodeficiency syndrome	0.000631	0.00294	CcSEcCtD
Auranofin—Angioedema—Nevirapine—acquired immunodeficiency syndrome	0.000627	0.00292	CcSEcCtD
Auranofin—Dysphagia—Saquinavir—acquired immunodeficiency syndrome	0.000619	0.00288	CcSEcCtD
Auranofin—Haematuria—Efavirenz—acquired immunodeficiency syndrome	0.000617	0.00288	CcSEcCtD
Auranofin—Anaemia—Nelfinavir—acquired immunodeficiency syndrome	0.000614	0.00286	CcSEcCtD
Auranofin—Anaemia—Stavudine—acquired immunodeficiency syndrome	0.000612	0.00285	CcSEcCtD
Auranofin—Thrombocytopenia—Didanosine—acquired immunodeficiency syndrome	0.00061	0.00284	CcSEcCtD
Auranofin—Neuropathy peripheral—Delavirdine—acquired immunodeficiency syndrome	0.000607	0.00283	CcSEcCtD
Auranofin—Stomatitis—Delavirdine—acquired immunodeficiency syndrome	0.000604	0.00281	CcSEcCtD
Auranofin—Jaundice—Delavirdine—acquired immunodeficiency syndrome	0.000604	0.00281	CcSEcCtD
Auranofin—Anaemia—Abacavir—acquired immunodeficiency syndrome	0.000603	0.00281	CcSEcCtD
Auranofin—Conjunctivitis—Delavirdine—acquired immunodeficiency syndrome	0.000602	0.00281	CcSEcCtD
Auranofin—Neutropenia—Ritonavir—acquired immunodeficiency syndrome	0.000601	0.0028	CcSEcCtD
Auranofin—Leukopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000595	0.00277	CcSEcCtD
Auranofin—Decreased appetite—Amprenavir—acquired immunodeficiency syndrome	0.000594	0.00277	CcSEcCtD
Auranofin—Anorexia—Didanosine—acquired immunodeficiency syndrome	0.000594	0.00277	CcSEcCtD
Auranofin—Leukopenia—Stavudine—acquired immunodeficiency syndrome	0.000593	0.00276	CcSEcCtD
Auranofin—Haematuria—Delavirdine—acquired immunodeficiency syndrome	0.000591	0.00275	CcSEcCtD
Auranofin—Dysphagia—Lamivudine—acquired immunodeficiency syndrome	0.00059	0.00275	CcSEcCtD
Auranofin—Pancytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000587	0.00274	CcSEcCtD
Auranofin—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.000584	0.00272	CcSEcCtD
Auranofin—Weight decreased—Ritonavir—acquired immunodeficiency syndrome	0.000581	0.00271	CcSEcCtD
Auranofin—Neutropenia—Saquinavir—acquired immunodeficiency syndrome	0.000578	0.0027	CcSEcCtD
Auranofin—Flatulence—Zidovudine—acquired immunodeficiency syndrome	0.000568	0.00264	CcSEcCtD
Auranofin—Dysgeusia—Zidovudine—acquired immunodeficiency syndrome	0.000564	0.00263	CcSEcCtD
Auranofin—Neuropathy peripheral—Ritonavir—acquired immunodeficiency syndrome	0.000562	0.00262	CcSEcCtD
Auranofin—Pancytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00056	0.00261	CcSEcCtD
Auranofin—Visual impairment—Efavirenz—acquired immunodeficiency syndrome	0.00056	0.00261	CcSEcCtD
Auranofin—Weight decreased—Saquinavir—acquired immunodeficiency syndrome	0.00056	0.00261	CcSEcCtD
Auranofin—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.000559	0.0026	CcSEcCtD
Auranofin—Stomatitis—Ritonavir—acquired immunodeficiency syndrome	0.000559	0.0026	CcSEcCtD
Auranofin—Jaundice—Ritonavir—acquired immunodeficiency syndrome	0.000559	0.0026	CcSEcCtD
Auranofin—Conjunctivitis—Ritonavir—acquired immunodeficiency syndrome	0.000557	0.0026	CcSEcCtD
Auranofin—Neutropenia—Lamivudine—acquired immunodeficiency syndrome	0.000552	0.00257	CcSEcCtD
Auranofin—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.000548	0.00256	CcSEcCtD
Auranofin—Dyspepsia—Didanosine—acquired immunodeficiency syndrome	0.000548	0.00256	CcSEcCtD
Auranofin—Haematuria—Ritonavir—acquired immunodeficiency syndrome	0.000546	0.00255	CcSEcCtD
Auranofin—Alopecia—Indinavir—acquired immunodeficiency syndrome	0.000544	0.00253	CcSEcCtD
Auranofin—Eye disorder—Efavirenz—acquired immunodeficiency syndrome	0.000543	0.00253	CcSEcCtD
Auranofin—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.000542	0.00252	CcSEcCtD
Auranofin—Neuropathy peripheral—Saquinavir—acquired immunodeficiency syndrome	0.000541	0.00252	CcSEcCtD
Auranofin—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.00054	0.00252	CcSEcCtD
Auranofin—Stomatitis—Saquinavir—acquired immunodeficiency syndrome	0.000538	0.0025	CcSEcCtD
Auranofin—Jaundice—Saquinavir—acquired immunodeficiency syndrome	0.000538	0.0025	CcSEcCtD
Auranofin—Conjunctivitis—Saquinavir—acquired immunodeficiency syndrome	0.000536	0.0025	CcSEcCtD
Auranofin—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.000534	0.00249	CcSEcCtD
Auranofin—Anaemia—Zidovudine—acquired immunodeficiency syndrome	0.000532	0.00248	CcSEcCtD
Auranofin—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000531	0.00247	CcSEcCtD
Auranofin—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.00053	0.00247	CcSEcCtD
Auranofin—Flatulence—Indinavir—acquired immunodeficiency syndrome	0.000528	0.00246	CcSEcCtD
Auranofin—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.000526	0.00245	CcSEcCtD
Auranofin—Dysgeusia—Indinavir—acquired immunodeficiency syndrome	0.000525	0.00244	CcSEcCtD
Auranofin—PRDX5—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000523	0.0312	CbGpPWpGaD
Auranofin—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000522	0.00243	CcSEcCtD
Auranofin—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.000517	0.00241	CcSEcCtD
Auranofin—Neuropathy peripheral—Lamivudine—acquired immunodeficiency syndrome	0.000516	0.0024	CcSEcCtD
Auranofin—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000516	0.0024	CcSEcCtD
Auranofin—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000516	0.0024	CcSEcCtD
Auranofin—Alopecia—Efavirenz—acquired immunodeficiency syndrome	0.000514	0.00239	CcSEcCtD
Auranofin—Jaundice—Lamivudine—acquired immunodeficiency syndrome	0.000513	0.00239	CcSEcCtD
Auranofin—Stomatitis—Lamivudine—acquired immunodeficiency syndrome	0.000513	0.00239	CcSEcCtD
Auranofin—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.000509	0.00237	CcSEcCtD
Auranofin—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.000508	0.00237	CcSEcCtD
Auranofin—Flatulence—Efavirenz—acquired immunodeficiency syndrome	0.000499	0.00232	CcSEcCtD
Auranofin—Visual impairment—Ritonavir—acquired immunodeficiency syndrome	0.000496	0.00231	CcSEcCtD
Auranofin—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.000496	0.00231	CcSEcCtD
Auranofin—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.000495	0.00231	CcSEcCtD
Auranofin—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000492	0.00229	CcSEcCtD
Auranofin—Alopecia—Delavirdine—acquired immunodeficiency syndrome	0.000492	0.00229	CcSEcCtD
Auranofin—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000491	0.00229	CcSEcCtD
Auranofin—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.000489	0.00228	CcSEcCtD
Auranofin—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000487	0.00227	CcSEcCtD
Auranofin—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000483	0.00225	CcSEcCtD
Auranofin—Eye disorder—Ritonavir—acquired immunodeficiency syndrome	0.000481	0.00224	CcSEcCtD
Auranofin—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000478	0.00223	CcSEcCtD
Auranofin—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.000477	0.00222	CcSEcCtD
Auranofin—Visual impairment—Saquinavir—acquired immunodeficiency syndrome	0.000477	0.00222	CcSEcCtD
Auranofin—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000476	0.00222	CcSEcCtD
Auranofin—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.000474	0.00221	CcSEcCtD
Auranofin—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000472	0.0022	CcSEcCtD
Auranofin—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.00047	0.00219	CcSEcCtD
Auranofin—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000468	0.00218	CcSEcCtD
Auranofin—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000468	0.00218	CcSEcCtD
Auranofin—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000463	0.00216	CcSEcCtD
Auranofin—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.000463	0.00216	CcSEcCtD
Auranofin—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000462	0.00215	CcSEcCtD
Auranofin—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000462	0.00215	CcSEcCtD
Auranofin—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00046	0.00214	CcSEcCtD
Auranofin—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000458	0.00213	CcSEcCtD
Auranofin—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000448	0.00209	CcSEcCtD
Auranofin—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000448	0.00209	CcSEcCtD
Auranofin—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000445	0.00207	CcSEcCtD
Auranofin—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000444	0.00207	CcSEcCtD
Auranofin—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000443	0.00206	CcSEcCtD
Auranofin—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000442	0.00206	CcSEcCtD
Auranofin—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000442	0.00206	CcSEcCtD
Auranofin—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.000441	0.00206	CcSEcCtD
Auranofin—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000441	0.00205	CcSEcCtD
Auranofin—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.000439	0.00204	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—CCL4—acquired immunodeficiency syndrome	0.000438	0.0261	CbGpPWpGaD
Auranofin—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000438	0.00204	CcSEcCtD
Auranofin—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000436	0.00203	CcSEcCtD
Auranofin—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000434	0.00202	CcSEcCtD
Auranofin—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000433	0.00202	CcSEcCtD
Auranofin—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000431	0.00201	CcSEcCtD
Auranofin—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000431	0.00201	CcSEcCtD
Auranofin—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00043	0.00201	CcSEcCtD
Auranofin—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00043	0.002	CcSEcCtD
Auranofin—IKBKB—GMCSF-mediated signaling events—CSF2—acquired immunodeficiency syndrome	0.000429	0.0256	CbGpPWpGaD
Auranofin—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000429	0.002	CcSEcCtD
Auranofin—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000428	0.00199	CcSEcCtD
Auranofin—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000428	0.00199	CcSEcCtD
Auranofin—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000426	0.00199	CcSEcCtD
Auranofin—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000425	0.00198	CcSEcCtD
Auranofin—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000423	0.00197	CcSEcCtD
Auranofin—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000422	0.00197	CcSEcCtD
Auranofin—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000421	0.00196	CcSEcCtD
Auranofin—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000417	0.00194	CcSEcCtD
Auranofin—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000417	0.00194	CcSEcCtD
Auranofin—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000414	0.00193	CcSEcCtD
Auranofin—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000414	0.00193	CcSEcCtD
Auranofin—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000409	0.0019	CcSEcCtD
Auranofin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000406	0.00189	CcSEcCtD
Auranofin—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000405	0.00189	CcSEcCtD
Auranofin—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000404	0.00188	CcSEcCtD
Auranofin—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000403	0.00188	CcSEcCtD
Auranofin—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000402	0.00187	CcSEcCtD
Auranofin—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000401	0.00187	CcSEcCtD
Auranofin—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000398	0.00186	CcSEcCtD
Auranofin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000396	0.00185	CcSEcCtD
Auranofin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000396	0.00185	CcSEcCtD
Auranofin—IKBKB—TWEAK Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.000394	0.0235	CbGpPWpGaD
Auranofin—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000394	0.00183	CcSEcCtD
Auranofin—Rash—Didanosine—acquired immunodeficiency syndrome	0.000393	0.00183	CcSEcCtD
Auranofin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000392	0.00183	CcSEcCtD
Auranofin—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000387	0.0018	CcSEcCtD
Auranofin—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000386	0.0018	CcSEcCtD
Auranofin—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000385	0.00179	CcSEcCtD
Auranofin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000384	0.00179	CcSEcCtD
Auranofin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000384	0.00179	CcSEcCtD
Auranofin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000383	0.00179	CcSEcCtD
Auranofin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000383	0.00178	CcSEcCtD
Auranofin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00038	0.00177	CcSEcCtD
Auranofin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.00038	0.00177	CcSEcCtD
Auranofin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000377	0.00176	CcSEcCtD
Auranofin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000377	0.00176	CcSEcCtD
Auranofin—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000376	0.00175	CcSEcCtD
Auranofin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000374	0.00174	CcSEcCtD
Auranofin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000373	0.00174	CcSEcCtD
Auranofin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000372	0.00173	CcSEcCtD
Auranofin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000371	0.00173	CcSEcCtD
Auranofin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00037	0.00172	CcSEcCtD
Auranofin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00037	0.00172	CcSEcCtD
Auranofin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000368	0.00171	CcSEcCtD
Auranofin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000365	0.0017	CcSEcCtD
Auranofin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000364	0.00169	CcSEcCtD
Auranofin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000359	0.00167	CcSEcCtD
Auranofin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000358	0.00167	CcSEcCtD
Auranofin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000357	0.00167	CcSEcCtD
Auranofin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000356	0.00166	CcSEcCtD
Auranofin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000353	0.00165	CcSEcCtD
Auranofin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000353	0.00165	CcSEcCtD
Auranofin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000353	0.00164	CcSEcCtD
Auranofin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000348	0.00162	CcSEcCtD
Auranofin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000348	0.00162	CcSEcCtD
Auranofin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000347	0.00162	CcSEcCtD
Auranofin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000346	0.00161	CcSEcCtD
Auranofin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000345	0.00161	CcSEcCtD
Auranofin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000344	0.0016	CcSEcCtD
Auranofin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000344	0.0016	CcSEcCtD
Auranofin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000344	0.0016	CcSEcCtD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—CCL4—acquired immunodeficiency syndrome	0.000342	0.0204	CbGpPWpGaD
Auranofin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000342	0.00159	CcSEcCtD
Auranofin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000342	0.00159	CcSEcCtD
Auranofin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000341	0.00159	CcSEcCtD
Auranofin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000341	0.00159	CcSEcCtD
Auranofin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000339	0.00158	CcSEcCtD
Auranofin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000338	0.00157	CcSEcCtD
Auranofin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000338	0.00157	CcSEcCtD
Auranofin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000336	0.00157	CcSEcCtD
Auranofin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000336	0.00156	CcSEcCtD
Auranofin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000335	0.00156	CcSEcCtD
Auranofin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000333	0.00155	CcSEcCtD
Auranofin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000333	0.00155	CcSEcCtD
Auranofin—IKBKB—BCR signaling pathway—CD79A—acquired immunodeficiency syndrome	0.000331	0.0197	CbGpPWpGaD
Auranofin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000329	0.00153	CcSEcCtD
Auranofin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000328	0.00153	CcSEcCtD
Auranofin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000327	0.00152	CcSEcCtD
Auranofin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000323	0.00151	CcSEcCtD
Auranofin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000322	0.0015	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—CD8A—acquired immunodeficiency syndrome	0.000322	0.0192	CbGpPWpGaD
Auranofin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000322	0.0015	CcSEcCtD
Auranofin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000322	0.0015	CcSEcCtD
Auranofin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000321	0.0015	CcSEcCtD
Auranofin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.00032	0.00149	CcSEcCtD
Auranofin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000318	0.00148	CcSEcCtD
Auranofin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000316	0.00147	CcSEcCtD
Auranofin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000314	0.00146	CcSEcCtD
Auranofin—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000313	0.00146	CcSEcCtD
Auranofin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000312	0.00146	CcSEcCtD
Auranofin—IKBKB—IL-4 Signaling Pathway—IL4—acquired immunodeficiency syndrome	0.000312	0.0186	CbGpPWpGaD
Auranofin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00031	0.00144	CcSEcCtD
Auranofin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000309	0.00144	CcSEcCtD
Auranofin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000306	0.00142	CcSEcCtD
Auranofin—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000301	0.0014	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—CCL3—acquired immunodeficiency syndrome	0.000299	0.0178	CbGpPWpGaD
Auranofin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000299	0.00139	CcSEcCtD
Auranofin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000299	0.00139	CcSEcCtD
Auranofin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000299	0.00139	CcSEcCtD
Auranofin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000296	0.00138	CcSEcCtD
Auranofin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000296	0.00138	CcSEcCtD
Auranofin—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—IFNA1—acquired immunodeficiency syndrome	0.000296	0.0176	CbGpPWpGaD
Auranofin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000295	0.00138	CcSEcCtD
Auranofin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000292	0.00136	CcSEcCtD
Auranofin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000292	0.00136	CcSEcCtD
Auranofin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00029	0.00135	CcSEcCtD
Auranofin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000289	0.00135	CcSEcCtD
Auranofin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000288	0.00134	CcSEcCtD
Auranofin—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000287	0.00134	CcSEcCtD
Auranofin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000283	0.00132	CcSEcCtD
Auranofin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00028	0.0013	CcSEcCtD
Auranofin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000279	0.0013	CcSEcCtD
Auranofin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000279	0.0013	CcSEcCtD
Auranofin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000278	0.0013	CcSEcCtD
Auranofin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000278	0.0013	CcSEcCtD
Auranofin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000276	0.00128	CcSEcCtD
Auranofin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000275	0.00128	CcSEcCtD
Auranofin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000274	0.00128	CcSEcCtD
Auranofin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00027	0.00126	CcSEcCtD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—MBL2—acquired immunodeficiency syndrome	0.00027	0.0161	CbGpPWpGaD
Auranofin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000267	0.00124	CcSEcCtD
Auranofin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.00124	CcSEcCtD
Auranofin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000263	0.00122	CcSEcCtD
Auranofin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.00121	CcSEcCtD
Auranofin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.00121	CcSEcCtD
Auranofin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00026	0.00121	CcSEcCtD
Auranofin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000259	0.0012	CcSEcCtD
Auranofin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000251	0.00117	CcSEcCtD
Auranofin—IKBKB—Type II diabetes mellitus—TNF—acquired immunodeficiency syndrome	0.00025	0.0149	CbGpPWpGaD
Auranofin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00025	0.00117	CcSEcCtD
Auranofin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.00116	CcSEcCtD
Auranofin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.00116	CcSEcCtD
Auranofin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000249	0.00116	CcSEcCtD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—CD79A—acquired immunodeficiency syndrome	0.000246	0.0147	CbGpPWpGaD
Auranofin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000245	0.00114	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IFNA1—acquired immunodeficiency syndrome	0.000244	0.0145	CbGpPWpGaD
Auranofin—IKBKB—Canonical NF-kappaB pathway—TNF—acquired immunodeficiency syndrome	0.000242	0.0144	CbGpPWpGaD
Auranofin—IKBKB—EBV LMP1 signaling—TNF—acquired immunodeficiency syndrome	0.000242	0.0144	CbGpPWpGaD
Auranofin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000241	0.00112	CcSEcCtD
Auranofin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.00111	CcSEcCtD
Auranofin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000235	0.00109	CcSEcCtD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—CCL3—acquired immunodeficiency syndrome	0.000234	0.0139	CbGpPWpGaD
Auranofin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.00108	CcSEcCtD
Auranofin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.00107	CcSEcCtD
Auranofin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.00107	CcSEcCtD
Auranofin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.00107	CcSEcCtD
Auranofin—IKBKB—Downstream TCR signaling—CD4—acquired immunodeficiency syndrome	0.000227	0.0135	CbGpPWpGaD
Auranofin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.00104	CcSEcCtD
Auranofin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.00103	CcSEcCtD
Auranofin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.00103	CcSEcCtD
Auranofin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.00101	CcSEcCtD
Auranofin—PRDX5—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	0.000217	0.0129	CbGpPWpGaD
Auranofin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000994	CcSEcCtD
Auranofin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.000986	CcSEcCtD
Auranofin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000985	CcSEcCtD
Auranofin—IKBKB—TCR Signaling Pathway—CD8A—acquired immunodeficiency syndrome	0.000211	0.0126	CbGpPWpGaD
Auranofin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.000974	CcSEcCtD
Auranofin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000929	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.000194	0.0115	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—CCR5—acquired immunodeficiency syndrome	0.000193	0.0115	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IFNA1—acquired immunodeficiency syndrome	0.00019	0.0113	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—CSF2—acquired immunodeficiency syndrome	0.000182	0.0109	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.000178	0.0106	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling—CD4—acquired immunodeficiency syndrome	0.00017	0.0101	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—CD4—acquired immunodeficiency syndrome	0.000155	0.00925	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.000151	0.00901	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000149	0.0089	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—CD79A—acquired immunodeficiency syndrome	0.000141	0.0084	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.00014	0.00837	CbGpPWpGaD
Auranofin—IKBKB—TNF receptor signaling pathway —TNF—acquired immunodeficiency syndrome	0.000139	0.00828	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	0.000121	0.00722	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.00012	0.00718	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—TNF—acquired immunodeficiency syndrome	0.00012	0.00717	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IFNA1—acquired immunodeficiency syndrome	0.000109	0.00648	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000105	0.00626	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.000104	0.00622	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL2—acquired immunodeficiency syndrome	9.63e-05	0.00574	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MBL2—acquired immunodeficiency syndrome	8.63e-05	0.00515	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TNF—acquired immunodeficiency syndrome	8.57e-05	0.00511	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	8.57e-05	0.00511	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—CSF2—acquired immunodeficiency syndrome	8.5e-05	0.00507	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	8.49e-05	0.00506	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HLA-B—acquired immunodeficiency syndrome	8.18e-05	0.00488	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	8.1e-05	0.00483	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—TNF—acquired immunodeficiency syndrome	7.97e-05	0.00475	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—acquired immunodeficiency syndrome	7.58e-05	0.00452	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL2—acquired immunodeficiency syndrome	7.55e-05	0.0045	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.53e-05	0.00449	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	7.34e-05	0.00438	CbGpPWpGaD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	6.85e-05	0.00409	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—acquired immunodeficiency syndrome	6.79e-05	0.00405	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CCR2—acquired immunodeficiency syndrome	6.77e-05	0.00403	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	6.76e-05	0.00403	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	6.75e-05	0.00402	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—acquired immunodeficiency syndrome	6.67e-05	0.00397	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	6.55e-05	0.0039	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	6.43e-05	0.00384	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—acquired immunodeficiency syndrome	6.43e-05	0.00384	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	6.32e-05	0.00377	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ACTG1—acquired immunodeficiency syndrome	6.12e-05	0.00365	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	6.09e-05	0.00363	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—IL6—acquired immunodeficiency syndrome	6.07e-05	0.00362	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	5.92e-05	0.00353	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	5.73e-05	0.00342	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	5.68e-05	0.00339	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL6—acquired immunodeficiency syndrome	5.66e-05	0.00337	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TNF—acquired immunodeficiency syndrome	5.5e-05	0.00328	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—IL6—acquired immunodeficiency syndrome	5.46e-05	0.00325	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	5.45e-05	0.00325	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	5.43e-05	0.00324	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—acquired immunodeficiency syndrome	5.13e-05	0.00306	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IFNG—acquired immunodeficiency syndrome	5.06e-05	0.00301	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MBL2—acquired immunodeficiency syndrome	5.03e-05	0.003	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	4.92e-05	0.00294	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	4.63e-05	0.00276	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	4.62e-05	0.00276	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	4.59e-05	0.00273	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	4.58e-05	0.00273	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	4.57e-05	0.00273	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.56e-05	0.00272	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.56e-05	0.00272	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	4.49e-05	0.00268	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	4.44e-05	0.00264	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	4.4e-05	0.00263	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	4.37e-05	0.0026	CbGpPWpGaD
Auranofin—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	4.24e-05	0.00253	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.12e-05	0.00246	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CCR2—acquired immunodeficiency syndrome	3.94e-05	0.00235	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	3.81e-05	0.00227	CbGpPWpGaD
Auranofin—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	3.61e-05	0.00215	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	3.58e-05	0.00213	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNA1—acquired immunodeficiency syndrome	3.55e-05	0.00212	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	3.52e-05	0.0021	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD79A—acquired immunodeficiency syndrome	3.45e-05	0.00205	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	2.87e-05	0.00171	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.82e-05	0.00168	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD40LG—acquired immunodeficiency syndrome	2.81e-05	0.00167	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	2.8e-05	0.00167	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD8A—acquired immunodeficiency syndrome	2.78e-05	0.00166	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CSF2—acquired immunodeficiency syndrome	2.78e-05	0.00166	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD4—acquired immunodeficiency syndrome	2.74e-05	0.00163	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-B—acquired immunodeficiency syndrome	2.67e-05	0.00159	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	2.64e-05	0.00157	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	2.63e-05	0.00157	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—acquired immunodeficiency syndrome	2.6e-05	0.00155	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.55e-05	0.00152	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.4e-05	0.00143	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.4e-05	0.00143	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.82e-05	0.00109	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.8e-05	0.00107	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNG—acquired immunodeficiency syndrome	1.65e-05	0.000985	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.64e-05	0.000979	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD4—acquired immunodeficiency syndrome	1.59e-05	0.000951	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.48e-05	0.000883	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	1.48e-05	0.000882	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2—acquired immunodeficiency syndrome	1.47e-05	0.000875	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.49e-06	0.000566	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—acquired immunodeficiency syndrome	8.63e-06	0.000514	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.58e-06	0.000332	CbGpPWpGaD
